Skip to main content
. 2022 Apr 29;3:211–217. doi: 10.1016/j.ijregi.2022.04.006

Table 1.

Demographic information of the participants who received Covishield vaccine.

n (%)
Participants enrolled 381
Sex
 Male 244 (64%)
 Female 137 (36%)
Age (years)
 <40 124 (33%)
 ≥40 257 (67%)
COVID-19 history before vaccination
 Positive 152 (40%)
 Negative 229 (60%)
Comorbiditiesa
 Unknownb 84 (22%)
 No 153 (40%)
 Yes 144 (38%)

COVID-19, coronavirus disease 2019.

a

Including asthma, hypertension, diabetes, heart diseases, kidney disease, etc.

b

Participants did not provide comorbidity data.